|
ADAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.241600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.389900E-04 |
| Normal-vs-Stage2 |
1.313010E-01 |
| Normal-vs-Stage3 |
2.13459999999221E-05 |
| Normal-vs-Stage4 |
2.135500E-03 |
| Stage1-vs-Stage2 |
2.290800E-01 |
| Stage1-vs-Stage3 |
2.083400E-01 |
| Stage1-vs-Stage4 |
5.185400E-01 |
| Stage2-vs-Stage3 |
7.914100E-02 |
| Stage2-vs-Stage4 |
1.901400E-01 |
| Stage3-vs-Stage4 |
7.966400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.166900E-04 |
| Normal-vs-AfricanAmerican |
2.676200E-01 |
| Normal-vs-Asian |
7.596100E-04 |
| Caucasian-vs-AfricanAmerican |
1.720760E-01 |
| Caucasian-vs-Asian |
5.381800E-01 |
| AfricanAmerican-vs-Asian |
8.871800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12410000000052E-05 |
| Normal-vs-Female |
1.235770E-03 |
| Male-vs-Female |
5.743700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.175020E-03 |
| Normal-vs-Age(41-60Yrs) |
1.436560E-04 |
| Normal-vs-Age(61-80Yrs) |
7.898800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.032400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.641200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.461200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.258400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.450400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.901800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.478200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.522980E-01 |
| Classical-VS-Follicular |
5.918200E-01 |
| Classical-VS-Other |
4.785900E-02 |
| Classical-VS-Normal |
1.555880E-03 |
| Tall-VS-Follicular |
2.967200E-01 |
| Tall-VS-Other |
1.447820E-01 |
| Tall-VS-Normal |
5.356100E-04 |
| Follicular-VS-Other |
1.307520E-02 |
| Follicular-VS-Normal |
5.139700E-03 |
| Other-VS-Normal |
1.457990E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.987100E-04 |
| Normal-vs-N1 |
1.242840E-03 |
| N0-vs-N1 |
4.210000E-01 |
|
|
